3 news items
HC Wainwright & Co. Reiterates Buy on Cocrystal Pharma, Maintains $10 Price Target
COCP
14 May 24
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Cocrystal Pharma (NASDAQ:COCP) with a Buy and maintains $10 price target.
Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
COCP
13 May 24
antiviral drug candidates that target the highly conserved regions of the viral enzymes, we seek to develop drugs that are effective against the virus
HC Wainwright & Co. Reiterates Buy on Cocrystal Pharma, Maintains $10 Price Target
COCP
4 Apr 24
HC Wainwright & Co. reiterates Cocrystal Pharma (NASDAQ:COCP) with a Buy and maintains $10 price target.
- Prev
- 1
- Next